In a study by Fornoni’s group involving 41 patients with high risk of FSGS recurrence, SMPDL3b levels in podocytes were found to be decreased in patients in who FSGS recurred. The gene discussed is SMPDL3B; the disease is focal segmental glomerulosclerosis.